Skip to main content
. 2020 Jul 4;9(7):2110. doi: 10.3390/jcm9072110

Table 2.

Medical therapy at baseline (BL).

Population
(N = 49)
Acetylsalicylic acid (ASA) 47 (95.9%)
Clopidogrel 29 (59.2%)
Prasugrel 13 (26.5%)
Ticagrelor 4 (8.1%)
Beta-blockers 41 (83.7%)
Nitrates 33 (67.3%)
Calcium channel blockers 4 (8.1%)
ACE inhibitors 41 (83.7%)
Angiotensin receptor Antagonists 9 (18.3%)
Statins 44 (89.8%)